Single-cell landscape of immune remodeling in alopecia areata suggests MIF + fibroblasts and their potential ligand-receptor crosstalk with dendritic cells - Top-Institutions - MDSpire

Single-cell landscape of immune remodeling in alopecia areata suggests MIF + fibroblasts and their potential ligand-receptor crosstalk with dendritic cells

  • By

  • Xuemei Lan

  • Haiyan Li

  • Yunting Xiao

  • May 22, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, NY

    Key Differentiators

    • Dermatology

  • #2

    Yale School of Medicine
    Yale School of Medicine

    New Haven, CT

    Key Differentiators

    • Dermatology

  • #3

    Hematology and Hemotherapy Center of the University of Campinas
    Hematology and Hemotherapy Center of the University of Campinas

    Campinas, SP

    Key Differentiators

    • Hematology
    • Dermatology

  • #4

    Necker Hospital
    Necker Hospital

    Paris, Île-de-France

    Key Differentiators

    • Dermatology

  • #5

    Kings College Hospital NHS Foundation Trust
    Kings College Hospital NHS Foundation Trust

    London, England

    Key Differentiators

    • Dermatology

Original Source(s)

Single-cell landscape of immune remodeling in alopecia areata suggests MIF + fibroblasts and their potential ligand-receptor crosstalk with dendritic cells

  • by Xuemei Lan, Haiyan Li, Yunting Xiao

  • May 22, 2026

Related Content

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Ivarmacitinib Eased Refractory PCA: Case Report

Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

Biologics Commonly Used in Cutaneous Crohn's Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn's disease.